AYTU AYTU BIOPHARMA, INC: institutional ownership and insider trading
40 funds reported holding $9.02M of AYTU BIOPHARMA, INC in their latest 13F filings; in Q2 2026 funds net sold $145K, with 3 new positions and 2 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding AYTU
- Two Sigma (Two Sigma Investments): $226K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $225K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $106K, 0.0% of the portfolio
Largest institutional holders of AYTU
- Nantahala Capital Management, LLC — $2.34M
- Stonepine Capital Management, LLC — $1.96M
- AWM Investment Company, Inc. — $1.33M
- VANGUARD GROUP INC — $724K
- VANGUARD CAPITAL MANAGEMENT LLC — $561K
- CROWN ADVISORS MANAGEMENT, INC. — $430K
- DIADEMA PARTNERS LP — $319K
- TWO SIGMA INVESTMENTS, LP — $226K
- RENAISSANCE TECHNOLOGIES LLC — $225K
- GEODE CAPITAL MANAGEMENT, LLC — $201K
Recent AYTU insider trades
- Jun 9, 2025: Disbrow Jarrett bought 16,666 shares ($25.0K)
- Jun 9, 2025: Disbrow Joshua R. bought 66,666 shares ($100.0K)
- Feb 28, 2025: Disbrow Joshua R. bought 15,000 shares ($19.5K)
5%+ owners
- Nantahala Capital Management, LLC: 14.4% (Schedule 13D/A, filed Jun 9, 2025)
- Stonepine Capital Management, LLC: 9.9% (Schedule 13G/A, filed Aug 13, 2025)
- Kanen Wealth Management LLC: 6.4% (Schedule 13G, filed Jun 26, 2025)
- AWM Investment Company, Inc.: 5.8% (Schedule 13G/A, filed Feb 13, 2026)